Provided by Tiger Fintech (Singapore) Pte. Ltd.

Klotho Neurosciences, Inc.

0.2050
+0.00995.07%
Post-market: 0.1900-0.0150-7.32%19:59 EDT
Volume:27.92M
Turnover:7.32M
Market Cap:6.66M
PE:-0.59
High:0.3151
Open:0.2100
Low:0.1995
Close:0.1951
Loading ...

Company Profile

Company Name:
Klotho Neurosciences, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
3
Office Location:
13576 Walnut Street,Suite A,Omaha,Nebraska,United States
Zip Code:
68144
Fax:
- -
Introduction:
Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Directors

Name
Position
Jiande Chen
Chief Executive Officer and Director
Edward Cong Wang
Chief Financial Officer and Director
Hong Li
Independent Director
Raymond J. Gibbs
Independent Director
Wei Kwang Ng
Independent Director

Shareholders

Name
Position
Jiande Chen
Chief Executive Officer and Director
Edward Cong Wang
Chief Financial Officer and Director